# Lyka Labs Ltd (LYKALABS)
> Exchange: NSE | Sector: Pharma | ISIN: INE933A01014

## Price
Current Price: ₹61.41
Day Change: +0.23%
52W High: ₹143.8
52W Low: ₹60.1
Market Cap: ₹219 Cr

## Valuation
P/E: 104.24
P/B: 2.17
EPS: ₹0.59
Book Value: ₹28.31
Dividend Yield: 0%

## Returns
1Y Return: -30.64%

## Profitability
ROE: 0%
ROCE: 0%
Debt/Equity: 0
Revenue Growth: 0%
Profit Growth: 0%
EBITDA Margin: -2.04%
Operating Margin: -0.68%

## About
Lyka Labs Ltd is a Biotechnology company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Biotechnology
Sub Industry: Unknown

## Business Model
Overview: Lyka Labs Ltd makes money through Technology services, Digital transformation projects, Maintenance and managed services in Biotechnology. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Technology services
- Digital transformation projects
- Maintenance and managed services
Operating Model:
- Wins client contracts, deploys skilled delivery teams, and earns project or recurring service revenue.
- Utilisation, billing rates, attrition, and currency movements are key operating levers.
Recent Context:
- Quarterly Report: Board Meeting Intimation for Approval Of Audited Results
- Announcement: Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
- BSE Filing: Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

## Access
Current tier: anonymous
More history: Register free to see 13 more years.

## Data Freshness
Quote Updated: 2026-05-24T20:00:13.396Z
Price History Updated: 2026-05-25T05:35:43.644Z
Latest Price History Date: 2026-05-24
Technicals Updated: 2026-05-25T05:35:43.644Z
Quant Updated: 2026-05-25T05:35:43.644Z
Sentiment Updated: 2026-05-25T05:35:43.644Z
Financials Status: current
Financials Updated: 2026-05-18T23:02:59.431Z
Financials Last Attempt: 2026-05-18T23:02:59.431Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (FY25)
Revenue: ₹133.56 Cr
Operating Profit: ₹11.19 Cr (OPM 8.38%)
Net Profit: ₹8.01 Cr
Tax: ₹3.19 Cr

## Annual P&L History
FY25: Rev ₹133.56Cr | PAT ₹8.01Cr | OPM 8.38%
FY24: Rev ₹105.13Cr | PAT ₹-2.49Cr | OPM 2.82%
FY23: Rev ₹88.34Cr | PAT ₹-13.21Cr | OPM 3.11%

## Balance Sheet (FY25)
Total Assets: ₹176.21 Cr
Total Liabilities: ₹72.62 Cr
Borrowings: ₹38.17 Cr
Cash: ₹0.39 Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Kunal Narendra Gandhi, MD, CEO, Promoter & Director
- Yogesh Babulal Shah, CFO & Executive Director
- Shailendra Kumar Agrawal CS, Company Secretary & Compliance Officer

---
Source: rupiya.io/stocks/lykalabs
Disclaimer: For research and education only. Not investment advice.